Evidence map›Paper›PMID 40573373›Full record

ArticleViruses2025

Evaluation of RT-LAMP for SARS-CoV-2 Detection in Animal Feces.

Aimee Pepper, Sandipty Kayastha, Megan Miller, Jake Guag, Andriy Tkachenko, Matthew Allender, Karen Terio, Leyi Wang

Abstract readEvaluation Study
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aimee PepperVeterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.
Sandipty KayasthaVeterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.
Megan MillerCenter for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD 20708, USA.
Jake GuagCenter for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD 20708, USA.
Andriy TkachenkoCenter for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD 20708, USA.
Matthew AllenderVeterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.ORCID 0000-0001-9067-1964
Karen TerioZoological Pathology Program, University of Illinois College of Veterinary Medicine, Brookfield, IL 60513, USA.ORCID 0000-0003-4924-5503
Leyi WangVeterinary Diagnostic Laboratory, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.ORCID 0000-0001-5813-9505

Funding

FDA HHS U18 FD007723Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) 1U18FD007723
6 · The paper itself

Abstract

The wide host range, potential lethality, and zoonotic potential of SARS-CoV-2 infection in animals highlights the need for additional surveillance strategies. We validated a commercial, pH-based, colorimetric RT-LAMP assay for the detection of SARS-CoV-2 RNA in animal feces. The comparator assay was rRT-PCR. The limit of detection of the RT-LAMP assay was 72 genome copies per reaction. RT-LAMP was highly specific for SARS-CoV-2 and did not detect other human or animal coronaviruses. RT-LAMP was robust, with valid results generated for incubation lengths of 30 to 45 min, incubation temperatures of 60 to 70 °C, and reaction volumes of 10 to 25 µL. The diagnostic sensitivity was 100% for clinical fecal samples with high viral loads (Ct ≤ 25), 97.4% for samples with moderate to high viral loads (Ct ≤ 33), and 62% overall (Ct ≤ 40). The diagnostic specificity was 97.9%. Blinded method testing organized by an independent laboratory confirmed the satisfactory reproducibility of the assay. To our knowledge, this study represents the first validation of RT-LAMP for SARS-CoV-2 detection in animals. RT-LAMP testing could detect SARS-CoV-2 infection more rapidly and at the point of care in animals with moderate to high viral loads, allowing for earlier implementation of control measures.

Indexed as

COVID-19COVID-19 Nucleic Acid TestingFecesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesSARS-CoV-2AnimalsHumansLimit of DetectionReproducibility of ResultsRNA, ViralSensitivity and SpecificityViral LoadRNA, ViralanimalsfecesrRT-PCRRT-LAMPSARS-CoV-2

Identifiers

PMID40573373
PMCPMC12197339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.